Literature DB >> 5630622

Corticosteroids in the treatment of optic nerve involvement associated with thyroid dysfunction.

R M Day, F D Carroll.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 5630622      PMCID: PMC1310259     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


× No keyword cloud information.
  8 in total

1.  Adrenal steroid therapy of severe infiltrative ophthalmopathy of Graves' disease.

Authors:  J BROWN; J W COBURN; R A WIGOD; J M HISS; J T DOWLING
Journal:  Am J Med       Date:  1963-06       Impact factor: 4.965

2.  Visual changes in progressive exophthalmos.

Authors:  J IGERSHEIMER
Journal:  AMA Arch Ophthalmol       Date:  1955-01

3.  The present status of ACTH and cortisone in clinical ophthalmology.

Authors:  A C WOODS
Journal:  Am J Ophthalmol       Date:  1951-07       Impact factor: 5.258

4.  Dysthyroid exophthalmos. Palliation by lateral orbital decompression.

Authors:  A J Kroll; V G Casten
Journal:  Arch Ophthalmol       Date:  1966-08

5.  Methylprednisolone in the treatment of exophthalmos.

Authors:  M I Garber
Journal:  Lancet       Date:  1966-04-30       Impact factor: 79.321

6.  Temporal decompression of the orbit for thyroid exophthalmos.

Authors:  J C Long; G D Ellis
Journal:  Am J Ophthalmol       Date:  1966-12       Impact factor: 5.258

7.  Adrenocorticotropic hormone ACTH and cortisone in ophthalmology; report of cases.

Authors:  H G SCHEIE; G S TYNER; J A BUESSELER; J E ALFANO
Journal:  AMA Arch Ophthalmol       Date:  1951-03

8.  The effect of cortisone and adrenocorticotrophic hormone on the concentration of circulating antibody.

Authors:  M BJØRNEBOE; E E FISCHEL; H C STOERK
Journal:  J Exp Med       Date:  1951-01       Impact factor: 14.307

  8 in total
  3 in total

1.  Reversal of dysthyroid optic neuropathy following orbital fat decompression.

Authors:  M Kazim; S L Trokel; G Acaroglu; A Elliott
Journal:  Br J Ophthalmol       Date:  2000-06       Impact factor: 4.638

2.  Clinical profile and visual outcomes after treatment in patients with dysthyroid optic neuropathy.

Authors:  Chan Jeon; Jae Ho Shin; Kyung In Woo; Yoon-Duck Kim
Journal:  Korean J Ophthalmol       Date:  2012-03-22

3.  Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

Authors:  M P Mourits; L Koornneef; W M Wiersinga; M F Prummel; A Berghout; R van der Gaag
Journal:  Br J Ophthalmol       Date:  1989-08       Impact factor: 4.638

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.